- Home
- FLC vs LFCR Comparison
FLC vs LFCR Comparison
Compare FLC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLC
- LFCR
- Stock Information
- Founded
- FLC 2003
- LFCR 1986
- Country
- FLC United States
- LFCR United States
- Employees
- FLC N/A
- LFCR N/A
- Industry
- FLC Trusts Except Educational Religious and Charitable
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- FLC Finance
- LFCR Health Care
- Exchange
- FLC Nasdaq
- LFCR Nasdaq
- Market Cap
- FLC 180.6M
- LFCR 164.3M
- IPO Year
- FLC N/A
- LFCR N/A
- Fundamental
- Price
- FLC $16.73
- LFCR $7.55
- Analyst Decision
- FLC
- LFCR Buy
- Analyst Count
- FLC 0
- LFCR 2
- Target Price
- FLC N/A
- LFCR $10.00
- AVG Volume (30 Days)
- FLC 37.8K
- LFCR 195.3K
- Earning Date
- FLC 01-01-0001
- LFCR 10-04-2024
- Dividend Yield
- FLC 6.64%
- LFCR N/A
- EPS Growth
- FLC N/A
- LFCR N/A
- EPS
- FLC N/A
- LFCR 0.17
- Revenue
- FLC N/A
- LFCR $128,443,999.00
- Revenue This Year
- FLC N/A
- LFCR $2.23
- Revenue Next Year
- FLC N/A
- LFCR $8.40
- P/E Ratio
- FLC N/A
- LFCR $45.01
- Revenue Growth
- FLC N/A
- LFCR 23.42
- 52 Week Low
- FLC $12.62
- LFCR $3.68
- 52 Week High
- FLC $15.45
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- FLC 44.53
- LFCR 56.70
- Support Level
- FLC $16.83
- LFCR $7.19
- Resistance Level
- FLC $17.03
- LFCR $7.88
- Average True Range (ATR)
- FLC 0.14
- LFCR 0.39
- MACD
- FLC 0.01
- LFCR -0.04
- Stochastic Oscillator
- FLC 34.78
- LFCR 55.91
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.